Skip to main content

Table 7 Pharmacokinetic parameters of FNDR-20123

From: Discovery of FNDR-20123, a histone deacetylase inhibitor for the treatment of Plasmodium falciparum malaria

 

Infected

Normal

Normal

Normal

Animal, strain

SCID mice

Balb/C mice

Balb/C mice

Balb/C mice

Route of administration

Oral

Oral

Subcutaneous

Intramuscular

Dose (mg/Kg)

50

50

50

50

Tmax (h)

1.00

1.00

0.08

0.08

Cmax (ng/mL)

460

184

14039

15654

AUClast (h*ng/mL)

1340

327

10,981

7224

t1/2 (h)

Not calculated

2.02

9.21

8.72

  1. Values are expressed as Mean ± SD
  2. N = 3 mice